Tagged with partner

Canada Referring to the Canadian affiliate of Zimmer Biomet as a “trailblazer”, Dave O’Neil looks back on a successful 2017 for the musculoskeletal healthcare company in Canada. He describes how Zimmer Biomet positions itself as a true partner in driving efficiency in the Canadian healthcare system. 2017 was an eventful year…

Canada Having just announced the first collaboration between a medical cannabis company and a major pharmaceutical player, Tilray expects to launch its first co-branded product with Sandoz Canada by the end of the year. Tilray’s founder and CEO Brendan Kennedy highlights the company’s main differentiation factors, including but not limited to…

Poland Dariusz Adamusiński, general manager of A&D Pharma’s Polish operations has a busy year ahead. A new warehouse in Poland, partnerships across the pharmaceutical spectrum coupled with new regulations are all positive signs for the company.  Could you introduce A&D Pharma’s scope of operations in Poland? “Many other pharma companies are…

Ecuador Francisco Cordero, general manager of Rocnarf, a proudly Ecuadorian family company with over 40 years of experience in the market discusses the company’s recent rebounding from experiencing severe price controls on its products. Looking forward, Cordero intends to develop international activities in collaboration with European, Middle Eastern and Central Asian…

Lithuania Aki Kasvi and Mindaugas Plieskis of Janssen Baltics discuss their strategic priorities, acting as a strategic partner within the region, and ensuring that patients can access their innovative latest-generation therapies Mr Kasvi, you were nominated to head up Janssen’s Lithuanian office back in November 2017. What was the strategic mission…

Canada Tarik Henein, president of Generic Medical Partners, explains the company’s commitment to improving the lives of Canadians by connecting global generic development and manufacturing companies with the Canadian market. He further comments on the key points for navigating the complex Canadian pharmaceutical market and how GMP combines a unique flexibility…

Serbia Founder and general director of INNventa, Goran Orlic, discusses the rationale behind establishing his own company that continues to double revenues year on year. He highlights the company’s fundamental role in providing innovative solutions to Serbian patients, pharmacists and doctors. Finally, he discusses investment opportunities in the Balkans, underlining the…

Switzerland Jeff Dufour, country manager Switzerland and BU lead Internal Medicine at Pfizer, discusses his first impressions of the country, his priorities for greater dialogue with Swiss healthcare insurers, and Switzerland’s potential as a ‘test market’ for the company. Can you give our international readers an outline of your background and…

Switzerland Marc Funk, COO of Swiss-headquartered product development service specialist, Lonza, discusses the company’s remarkable recent fortunes, how it is implementing innovative efficiency improvements, and answers the question, “why Switzerland?”   We aspire to move the company and the relationship with our customers from being a functional service provider to the strategic partner…

Canada Paul-Émile Cloutier, president & CEO of HealthCareCAN, the national voice of healthcare organizations and hospitals across Canada, highlights his ambition to make HealthCareCAN the go-to resource on healthcare system topics, the importance of bridging the gap between innovation and health, and his philosophy on the key elements supporting fruitful partnerships.…

Switzerland In an exclusive interview, Jean-Paul Clozel, former head of Actelion and now CEO of exciting biotech newcomer Idorsia, discusses his new company’s unique drug discovery methodology, the pressure of past success, and how he hopes to usher in a new era of collaboration to tackle disease.   In August 2016,…

Tunisia Ramzi Lebbi, general director and co-founder of mc PHARMA, a Tunisian medical information and promotion agency, describes the company’s evolution since its foundation 15 years ago, its service provider activities for multinational companies, and the potential expansion of its portfolio of services. Mr. Lebbi, looking back at mc PHARMA’s creation,…